The increasing adoption of multiplex point-of-care (POC) tests is reshaping diagnostics. By 2029, it’s projected that the global market for multiplex diagnostics will exceed $42 billion, growing at a compound annual growth rate (CAGR) of 16.2% from 2023. This growth underscores the burgeoning demand for efficient, cost-effective, and highly precise medical testing. Let’s delve deeper
Healthcare facilities face the ongoing challenge of enhancing efficiency and improving patient outcomes. This is particularly crucial during peak periods of respiratory ailments. The decision to integrate new technologies like multiplex testing into clinical practices is one that many healthcare stakeholders grapple with. At Cost Plus Med Tech, we advocate for the adoption of multiplex testing methods.
The chill of winter often brings with it not only the joy of holiday gatherings but also the peak of flu season. With increasing travel activities, particularly around the holidays, the risk of spreading influenza escalates, affecting celebrations. According to a 2023 holiday travel survey by Deloitte, a significant 48% of Americans are planning to
